Staphylococcus Aureus Protein A Immunoadsorption: The Rationale for Systemic Protein A Immunotherapy

Toxicology Methods

Volumn 7, Issue 1, 1997, Pages 9-15

  Cowan, Fred M ^a  

^a US ARMY MEDICAL RESEARCH INSTITUTE OF CHEMICAL DEFENSE   (United States)

Author keywords

Extracorporeal; Fc receptor; Immunoglobulin binding factor; Staphylococcus aureus protein A

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

EID: 0004672728     PISSN: 10517235     EISSN: None     Source Type: Journal    
DOI: 10.1080/105172397243277     Document Type: Article

References (41)

1. Bansal SC, Bansal BR, Thomas HL, et al. Ex vivo removal of serum IgG in a patient with colon carcinoma: some biochemical, immunological and histological observations. Cancer. 1978;42:1-18.
2. Snyder HW Jr, Balint JP, Jones FR. Modulation of immunity and clinical responses in patients with cancer and autoimmune disease treated by extracorporeal immunoadsorption of plasma with protein A-silica (PROSORBA columns). Semin Hematol. 1989;26:31-41.
3. Terman DS, Young JB, Shearer WT. Preliminary observations of the effects on breast adenocarcinoma of plasma infused over immobilized protein A. N Engl J Med. 1981;305:1159-1200.
4. Messerschmidt GL, Henry DH, Snyder HW Jr, et al. Protein A immunoadsorption in the treatment of malignant disease. J Clin Oncol. 1988;6:203-212.
5. Kinet, JP, Bensinger, WI, Balland, et al. Ex vivo perfusion of plasma over protein A columns in human mammary adenocarcinoma: role of Fc-binding capacity of protein A in the side effects and the tumoricidal response. Eur J Clin Invest. 1986;16:50-55.
6. Howe RB, Christie, DJ. Protein A immunoadsorption treatment in hematology: an overview. J Clin Apheresis. 1994;9:31-32.
7. Wiesenhutter CW, Irish BL, Bertram JH. Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immunoadsorption columns: a pilot trail. J Rheumatol. 1994;21:804-812.
8. Snyder HW, Cochran SK, Balint JP Jr, et al. Experience with Protein A-Immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura. Blood. 1992;79:2237-2245.
9. Sinclair NR StC. Antibody-antigen complexes: biological consequences. In: Encyclopedia of Hutman Biology, Vol 1. New York: Academic; 1991:297-305.
10. Fridman WH. Fc receptors and immunoglobulin binding factors. FASEB J. 1991;5:2684-2690.
11. Sandor M, Lynch RG. The biology and pathology of Fc receptors. J Clin Immunol. 1993;4:237-246.
12. Ravetch JV. Fc receptors: Rubor redux. Cell. 1994;78:553-560.
13. Wallace PK, Howell AL, Fanger MW. Role of Fc receptors in cancer and infectious disease. J Leukocyte Biol. 1994;55:816-826.
14. Cowan FM. A method of treating cellular Fc receptor mediated immune disorders. U.S. Patent Number: 5,189,014, 23 February 1993 (original application Serial No. 99, 741 filed 3 December 1979).
15. Cowan FM, Madsen JM. The role of immunoglobulin binding factors in the pathogenesis and therapy of AIDS. Med Hypothesis. 1994;43:172-176.
16. Cambier JC. Antigen and Fc receptor signaling: the awesome power of the immunoreceptor tryosine-based activation motif (ITAM). J Immunol. 1995;155:3281-3285.
17. Chamow SM, Ashkenazi A. Immunoadhesesins: principles and applications. TIBTECH 1996;14:52-60.
18. Ray PK, Raychaudhari S, Allen P. Mechanisms of regression of mammary adenocarcinoma in rats following plasma adsorption over Protein A containing Staphylococcus aureus. Cancer Res. 1982;42: 4970.
19. Cowan FM, Klein DL, Armstrong GR, Pearson JW, Ablashi DV, Bensinger WI. Inhibition of rat adenocarcinoma metastases by Staphylococcus aureus protein A. Pharmacotherapy. 1982;36:29-31.
20. Engelman RW, Good RA, Day NK. Clearance of retroviremia and regression of malignancy in cats with leukemia-lymphoma during treatment with Staphylococcal protein A. Cancer Detect Prev. 1987;10:435-444.
21. Das C, Langone JL. Dissociation between murine spleen cell mitogenic activity of enterotoxin contaminants and anti-tumor activity of staphylococcal protein A. J Immunol. 1989;142:2943-2948.
22. Singh KP, Shau H, Gupta RK, Kopald K, Ray PK. Protein A potentiates lymphokine-activated killer cell induction in normal and melanoma patient lymphocytes. Immunopharmacol Immunotoxicol. 1992;14:79-103.
23. Hjelm H, Sjodahl J, Sjoquist J. Immunologically active and structurally similar fragments of protein A from Staphylococcus aureus. EurJ Biochem. 1975;57:395-403.
24. Cowan FM, Klein DL, Armstrong GR, Stylos WA, Pearson JW. Suppression of DNA synthesis in mitogen stimulated leukocytes with partial trypsin digests of Staphylococcus aureus protein A. Biomedicine. 1979;31:220-222.
25. Lopez DA, Williams RM, Miehlke K. Enzymes: The Fountain of Life. Charleston, SC: Neville; 1994.
26. Godfrey MAJ, Kwasowski P, Clift R, Marks V. A sensitive enzyme-linked immunosorbent assay (ELISA) for the detection of staphylococcal protein A c(SpA) present as a trace contaminant of murine immunoglobulins purified on immobilized protein A. J Immunol Methods. 1992;149:21-27.
27. Friberger P. Chromogenic peptide substrates. Scand J Clin Invest. 1991;42:1-98.
28. Twining SS. Fluorecein isothiocyanate-labeled casein assay for proteolytic enzymes. Anal Biochem. 1984;143:30-34.
29. Forgren A, Sjoquest J. Protein A from Staphylococcus aureus, IV: production of anaphylaxis-like cutaneous and systemic reactions in nonimmunized guinea pigs. J Immunol. 1967;100:530-534.
30. Cowan FM, Shih T-M, Lenz DE, Madsen JM, Broomfield CA. A hypothesis for synergistic toxicity of organophosphorus poisoning-induced cholnergic crisis and anaphylactoid reactions. J Appl Toxicol. 1996;16:25-33.
31. Smith RE, Gottschall JL, Pisciotta AV. Life-threatening reactions to staphylococcal protein A immunomodulation. J Clin Apheresis. 1992;7:4-5.
32. Arbiser JL, Dzieczkowski JS, Harmon JV, Duncan LM. Leukocytoclastic vasculitis following Staphylococcal protein A column immunoadsorption therapy. Arch Dermatol. 1995;131:707-709.
33. Debre M, Bonnet M-C, Fridman W-H, et al. Infusion of Fc fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet. 1993;342:945-949.
34. 2 protein A interaction. Scand J Immunol. 1981;13:343.
35. 2 that bind to Staphylococcus protein A belong to the VHIII subgroup. J Immunol. 1991;147:1877-1883.
36. H3 gene products: natural ligands for HIV gp 120. Science. 1993;261:1588-1591.
37. Silverman GJ. Human antibody responses to bacterial antigens: studies of a model conventional antigen and a proposed model B cell superantigen. Int Rev Immunol. 1992;9:57-78.
38. Ashman RF, Peckham D, Stunz LL. Fc receptor off-signal in B cell involves apoptosis. J Immunol. 1996;157:5-11.
39. Sinclair NR StC, Panoskaltsis A. Immunoregulation and Fc signals. Immunol Today. 1987;8:76-79.
40. Romagnani SMG, et al. Demonstration on protein A of two distinct immunoglobulin-binding sites and their role in the mitigenic activity of Staphylococcus aureus Cowan I on human B cells. J Immunol. 1982;129:596.
41. Zaidi SIA, Raisuddin S, Jafri A, Singh KP, Ray PK. Modulation of anti-sheep erythrocyte primary antibody response by protein A in normal mice. Immunopharmacol Immunotoxicol. 1994;16:85-96.